Does Martek Hold A Key To Treating Alzheimer's Disease?

Everyone knows about the current and future epidemic of Alzheimer's Disease. This disease is largely untreated and most current treatments gear around early diagnosis, slowing the onset, or prolonging the early stages from becoming late-stage Alzheimer's. Martek Biosciences Corp. (NASDAQ: MATK) has made an announcement this morning about its DHA from microalgae being a possible component in combating Alzheimer's. The problem is that this was published in December and this looks very preliminary from a mice study.

Barron's had covered this last year with an article outlining the drug developments from Big Pharma and we ourselves have noted what this may end up doing to the nursing home operations in the U.S. and elsewhere.
In a recent pre-clinical study published in the December 26 issue of the Journal of Neuroscience, an omega-3 fatty acid found in algae called docosahexaenoic acid (or DHA), was found to decrease an important risk factor for late-onset Alzheimer's disease
click here for the whole story